ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00843440
Brief Title: Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study (METAFORE)

First Submitted : February 12, 2009
First Submitted that Met QC Criteria : February 12, 2009
First Posted : February 13, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : May 29, 2013
Last Update Posted : May 30, 2013 (Estimate)